2012 Clinical Trials Consumption Epilepsy 
The Cannigma
MARCH 7, 2022
Interestingly, smoking (combustion) is believed to produce the most CBN when consumed, which could be due to higher temperatures that are achieved during consumption. A 2012 study in rats compared the effects of CBD, CBG, and CBN on food consumption and showed that unlike the others, CBN increased feeding.
The Cannigma
JUNE 15, 2021
The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. The perception that CBD is a wonder-drug version of cannabis — particularly known for its uses to treat epilepsy — that doesn’t get you high.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Greencamp
AUGUST 16, 2018
The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). 16: Cannabis; June 2012, Pages 400-404.
Cannabis Law Report
NOVEMBER 24, 2021
Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. years (Atakan 2012 ). Refractory paediatric epilepsy. Conclusions. 2016 ; Sznitman et al. Palliative care indications. Cancer pain. Neuropathic pain.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Lancet Neurol Dec 23 2015.
Expert insights. Personalized for you.
140 
Let's personalize your content